We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Autosomal Dominant Disorder Confirmed by Biomarker Assay

By LabMedica International staff writers
Posted on 06 Feb 2012
The erythrocyte glucose-uptake assay has been used to confirm the diagnosis of glucose transporter type 1 deficiency syndrome (Glut1-DS). More...


The disease is diagnosed with cerebrospinal fluid (CSF) glucose values of less than 2.2 mmol/L, or lowered CSF/plasma glucose ratio of less than 0.4, and the erythrocyte 3-O-methyl-d-glucose uptake assay (3-OMG).

Scientists at Columbia University (New York, NY, USA) studied 109 suspected cases of Glut-1 DS, all who had a consistent clinical picture and a low CSF glucose concentration (hypoglycorrhachia). To confirm the diagnosis of Glut1 DS, blood samples from both patients and parents were analyzed using the erythrocyte 3-OMG uptake assay. The erythrocytes are radioactively labeled and measured on a scintillation counter.

Copy number analysis was performed via single nucleotide polymorphism (SNP) oligonucleotide microarray analysis (SOMA) using the Affymetrix Genome Wide Human SNP Array 6.0 (Santa Clara, CA, USA), which includes over 906,600 SNPs and more than 946,000 probes for the detection of copy number variation. A multiplex ligation-dependent probe amplification (MLPA) kit (MRC-Holland; Amsterdam, Netherlands) was used to screen eight patients with decreased 3-OMG uptake without identified sequence based mutations or deletions using SOMA. .

The uptake assay was decreased in 74 cases (group 1) and normal in 35 cases (group 2). The disease-causing mutations were identified in 70 group 1 patients (95%) and only one in group 2 patients (3%). The cut-off for an abnormally low uptake value was increased from 60% to 74% with a corresponding sensitivity of 99% and specificity of 100%. The correlation between the uptake values for the time-curve and the kinetic concentration curve were strongly positive. There was a significant correlation between the mean erythrocyte 3-OMG uptake and clinical severity.

The authors concluded that the erythrocyte glucose-uptake assay, when abnormal, essentially confirms the clinical suspicion of Glut1 DS. Furthermore, the degree of uptake abnormality correlates with glucose transport functional activity and has implications regarding clinical severity and prognosis. Glut1 deficiency syndrome is characterized classically by infantile onset seizures, delayed neurological development, disorders of movement, and acquired microcephaly. The study was published in December 2011, in the Annals of Neurology.

Related Links:

Columbia University
Affymetrix
MRC-Holland



New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Serological Pipet Controller
PIPETBOY GENIUS
New
Silver Member
Quality Control Material
NATtrol Chlamydia trachomatis Positive Control
New
Anterior Nasal Specimen Collection Swabs
53-1195-TFS, 53-0100-TFS, 53-0101-TFS, 53-4582-TFS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: Pancreas cells (left) showing early stages of malignant cancer in brown and same cells stained blue (right) indicate they are Integrin β3 (ITGB3) positive (Photo courtesy of UC San Diego Health Sciences)

Gene Signature Could Serve as Early Warning System for Aggressive Pancreatic Cancer

Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive and lethal forms of cancer, with early detection remaining a major challenge. Precancerous cells must overcome significant stress and... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Microbiology

view channel
Image: The groundbreaking salmonella antimicrobial resistance prediction platform has demonstrated 95% accuracy (Photo courtesy of Yujie You et al., DOI: 10.1016/j.eng.2025.01.013)

New Platform Leverages AI and Quantum Computing to Predict Salmonella Antimicrobial Resistance

Antimicrobial-resistant Salmonella strains are a growing public health concern due to the overuse of antimicrobials and the rise of genetic mutations. Accurate prediction of resistance is crucial for effective... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.